Dernières nouvelles pour Virgin Galactic Hldgs (NYSE:SPCE) Stock

Virgin Galactic Hldgs

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

Virgin Galactic Holdings, Inc. Common Stock

Virgin Galactic Holdings Inc

Goldman Sachs analyst Neil Mehta maintains Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) with a Buy and lowers the price target from $27 to $24.

News

Price Target

Analyst Ratings

Goldman Sachs Maintains Buy on Halliburton, Lowers Price Target to $24

Stock Split

PLRZ

Reported May 1, 2025: Polyrizon Announced The Planned Reverse Share Split Of The Company's Ordinary Shares At The Ratio Of 1-For-10 That Was Previously Announced On May 1, 2025, Will Not Be Effectuated

Stephens &amp; Co. analyst Matt Olney maintains Cullen/Frost Bankers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFR#NYSE">CFR</a>) with a Equal-Weight and raises the price target from $138 to $141.

Stephens & Co. Maintains Equal-Weight on Cullen/Frost Bankers, Raises Price Target to $141

Goldman Sachs analyst Kate McShane maintains Floor &amp; Decor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FND#NYSE">FND</a>) with a Sell and lowers the price target from $81 to $70.

Goldman Sachs Maintains Sell on Floor & Decor Hldgs, Lowers Price Target to $70

Goldman Sachs analyst Will Nance maintains Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) with a Buy and lowers the price target from $65 to $57.

Goldman Sachs Maintains Buy on Block, Lowers Price Target to $57

Stephens &amp; Co. analyst Brett Huff maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Equal-Weight and lowers the price target from $255 to $221.

TEAM

Stephens & Co. Maintains Equal-Weight on Atlassian, Lowers Price Target to $221

Goldman Sachs analyst Paul Choi maintains Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) with a Neutral and lowers the price target from $12 to $8.

ARVN

Goldman Sachs Maintains Neutral on Arvinas, Lowers Price Target to $8

Goldman Sachs analyst Salveen Richter maintains Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) with a Neutral and lowers the price target from $12 to $9.

FOLD

Goldman Sachs Maintains Neutral on Amicus Therapeutics, Lowers Price Target to $9

In the high-stakes world of humanoid robotics, <a href="https://www.benzinga.com/topic/electric-vehicle">two EV titans</a> — Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and XPeng Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) — are competitors transforming this sector.
A CNBC <a href="https://www.cnbc.com/2025/04/29/how-to-play-a-5-trillion-market-for-humanoid-robots-by-2050.html">report </a>suggests that Morgan Stanley projects a $5 trillion global market for humanoid robots by 2050. Facts reveal that the race to dominate this new frontier is shaping up to be less &#8220;Fast &amp; Furious,&#8221; more &#8220;Iron Man&#8221; vs. &#8220;Iron Man.&#8221;
<h1 class="wp-block-heading">Optimus: Tesla&#8217;s FSD Tech-Powered Humanoid</h1>
Tesla&#8217;s Optimus is the better-known name, touted by Elon Musk as a full-stack humanoid built to tackle &#8220;mundane, repetitive, or dangerous tasks.&#8221; It stands at 5'8", powered by Tesla's Full Self-Driving (FSD) technology and integrates seamlessly with the company's vertically aligned AI and hardware ecosystem.
Optimus is expected to begin mass production this year, pending a little red tape from China. Rare earth export restrictions have thrown a wrench into Musk's plans, with the Chinese government scrutinizing the use of rare earth magnets amid geopolitical tensions. Musk insists the bots aren't weapons, but regulators still want assurances. That delay could slow down the thousands of Optimus units Tesla aims to build this year.
Read Also: <a href="https://www.benzinga.com/25/05/45134925/chinese-ev-companies-see-huge-april-growth-xpeng-surges-273-in-deliveries">Tesla&#8217;s Chinese Rivals See Huge April Growth, XPeng Surges 273% In Deliveries</a>
<h1 class="wp-block-heading">Iron: XPeng Blending Mobility &amp; Robotics In China</h1>
Enter XPeng's Iron, a <a href="https://carnewschina.com/2025/04/30/xpeng-showcases-humanoid-robot-iron-used-for-making-its-vehicls/">new contender</a> fresh off its Shanghai Auto Show flex. Iron isn't just hype — it's already working the production lines at XPeng, assembling EVs with precision. Standing at the same height as Optimus but packing more digital muscle — 3,000 TOPS of processing power, to be exact.
XPeng is literally putting Iron to work while Tesla navigates diplomatic speed bumps.
XPeng's edge lies in real-world deployment. Iron draws on the same AI that powers XPeng's autonomous vehicles, creating an end-to-end smart ecosystem that blends mobility and robotics. Its proprietary "Turing AI chip" and "Tianji AIOS" power everything from spatial awareness to voice interaction. With 60 joints and 200 degrees of freedom, Iron walks and works with a fluidity that&#8217;s caught the industry's eye.
<h1 class="wp-block-heading">62.7M Jobs &amp; A Trillion-Dollar Tech Transformation</h1>
Morgan Stanley calls Tesla a top potential winner due to its full-stack integration, but XPeng's Iron is proving it can punch above its weight. Both companies are chasing a future where humanoids take over not just factories but households and retail spaces. With projections of 62.7 million jobs replaced by robots by 2050 and a billion bots in use, this isn't science fiction — it's a trillion-dollar tech transformation.
So, who will build the next &#8220;Tony Stark&#8221; suit? Tesla may have the brand and brain trust, but XPeng is putting boots — or at least, metal feet — on the ground first.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45162888/uber-heats-up-robotaxi-battle-against-tesla-waymo-with-may-mobility-deal">Uber Heats Up Robotaxi Battle Against Tesla, Waymo With May Mobility Deal</a></li>
</ul>
Photos: Shutterstock

Long Ideas

Global

Tech

Trading Ideas

TSLA

XPEV

Tesla's Optimus Vs. XPeng's Iron: The $5 Trillion 'Iron Man' Showdown

Goldman Sachs analyst Salveen Richter maintains Adaptive Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADPT#NASDAQ">ADPT</a>) with a Buy and raises the price target from $9 to $10.

ADPT

Goldman Sachs Maintains Buy on Adaptive Biotechnologies, Raises Price Target to $10

Stephens &amp; Co. analyst Daniel Imbro maintains Canadian National Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) with a Equal-Weight and raises the price target from $105 to $109.

Stephens & Co. Maintains Equal-Weight on Canadian National Railway, Raises Price Target to $109

Shares of ECARX Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECX#NASDAQ">ECX</a>) are rebounding after initially dropping following the company's first quarter 2025 earnings report <a href="https://www.benzinga.com/pressreleases/25/04/g45095562/ecarx-announces-first-quarter-2025-unaudited-financial-results">earlier this week.</a>
What To Know: The company posted a net loss of 8 cents per share for the quarter, which was an improvement from the 12 cents loss in the same period last year. Revenue came in at $168.5 million, exceeding analyst expectations of $154.18 million and marking a 31% year-over-year increase.
The company's performance was driven by growth in software and service revenue, which offset some of the pressure from pricing strategy changes that affected hardware margins. Gross profit rose to $33.5 million, with a margin of 20%, slightly down from 22% last year. Total units shipped in the quarter reached 684,000, pushing the number of vehicles on the road with ECARX technology to over 8.7 million. The firm continues to expand its relationship with Geely, securing eight new projects tied to the automaker's latest E/E architecture.
Despite the operational progress, ECARX remains unprofitable. Its net loss narrowed to $27 million, down from $304 million a year ago. Adjusted EBITDA loss also improved significantly to $14.4 million, compared to a $31 million loss previously. Research and development, as well as administrative expenses, both declined year-over-year.
Product innovation continued, with the Antora 1000 SPB computing platform completing road testing and the rollout of ECARXperience, an AI-powered in-car interface system. ECARX also raised $45 million in a public offering to support global expansion, including new facilities in Singapore. 
ECX Price Action: Ecarx shares were up 5.22% at $1.41 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="569" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02115431/Screenshot-2025-05-02-at-11.54.12-1024x569.png" alt="" class="wp-image-899517" style="width:420px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02115431/Screenshot-2025-05-02-at-11.54.12-1024x569.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02115431/Screenshot-2025-05-02-at-11.54.12-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02115431/Screenshot-2025-05-02-at-11.54.12-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02115431/Screenshot-2025-05-02-at-11.54.12.png 1493w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45170765/trumps-first-100-days-fuel-gold-crush-stocks-bofa-strategist-sees-soft-macro-masked-by-hard-ai-bets">Trump&#8217;s First 100 Days Fuel Gold, Crush Stocks: BofA Strategist Sees Soft Macro Masked By Hard AI Bets</a></li>
</ul>
Image Via Shutterstock.

Movers

What's Going On With ECARX Shares Today?

Stephens &amp; Co. analyst Daniel Imbro maintains Rush Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUSHA#NASDAQ">RUSHA</a>) with a Overweight and lowers the price target from $63 to $61.

RUSHA

Stephens & Co. Maintains Overweight on Rush Enterprises, Lowers Price Target to $61

Raymond James analyst Brian Peterson maintains Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) with a Outperform and lowers the price target from $125 to $105.

Raymond James Maintains Outperform on Workiva, Lowers Price Target to $105

Raymond James analyst Bobby Griffin reiterates Upbound Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPBD#NASDAQ">UPBD</a>) with a Outperform and lowers the price target from $40 to $35.

Reiteration

UPBD

Raymond James Reiterates Outperform on Upbound Group, Lowers Price Target to $35

WIIM

UBER

Uber Technologies shares are trading higher after the company announced an agreement with Momenta to introduce autonomous vehicles to the platform, in international markets outside of the US and China.

Raymond James analyst Robert Dodd maintains Sixth Street Specialty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSLX#NYSE">TSLX</a>) with a Outperform and lowers the price target from $24 to $23.

TSLX

Raymond James Maintains Outperform on Sixth Street Specialty, Lowers Price Target to $23

Raymond James analyst Brian Vaccaro reiterates Shake Shack (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHAK#NYSE">SHAK</a>) with a Strong Buy and lowers the price target from $145 to $140.

SHAK

Raymond James Reiterates Strong Buy on Shake Shack, Lowers Price Target to $140

Guggenheim analyst Steven Forbes maintains Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) with a Buy and lowers the price target from $60 to $50.

Guggenheim Maintains Buy on Wayfair, Lowers Price Target to $50

Raymond James analyst David Feaster reiterates Riverview Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSB#NASDAQ">RVSB</a>) with a Outperform and raises the price target from $6.25 to $7.

Comments

Virgin Galactic Hldgs

Actualités

Dernières nouvelles pour Virgin Galactic Hldgs (NYSE:SPCE) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL